Neuronetics Q3 Revenue $42.0M, Operating Profit $541K — But March 2027 Covenant Breach Looms
STIM has more than doubled off its 52-week low of $0.8.
Summary
Neuronetics posted Q3 revenue of $42.0 million and its first quarterly operating profit, but disclosed it expects to miss its March 31, 2027 revenue covenant, which could let the lender call the $65.0 million credit facility it cannot repay.
Key Events · Earnings and Guidance · STIM
-
Q3 Revenue Grows 13% to $42.0M
Total revenue rose to $41,962 thousand from $37,297 thousand a year earlier, led by Greenbrook revenue of $26,192 thousand (up 20%) while NeuroStar was roughly flat at $15,770 thousand.
-
First Quarterly Operating Profit
Gross margin expanded to 52.2% from 45.9% and sales and marketing expense fell 28% to $8,484 thousand, producing income from operations of $541 thousand versus a $7,321 thousand loss in Q3 2025.
-
March 2027 Covenant Breach Projected
Management projects trailing twelve-month revenue for the period ended March 31, 2027 will be below the credit agreement minimum; if the lender calls the $65.0 million facility, the Company is not projected to have the liquidity to repay it.
-
Cash Down to $22.1M on $9.2M Burn
Cash and cash equivalents were $22,106 thousand at September 30, 2026 versus $28,134 thousand at December 31, 2025, after $9,191 thousand of net cash used in operating activities in the first nine months.
Analysis · STIM · Industrial Applications And Services
The quarter itself was the best Neuronetics has posted: revenue of $42.0 million, gross margin up to 52.2% from 45.9%, and a $541 thousand operating profit versus a $7.3 million operating loss a year ago. What keeps this at a high score is the balance sheet behind it. Cash fell to $22.1 million from $28.1 million at year-end while operations burned $9.2 million in nine months, and management now projects trailing twelve-month revenue for the period ended March 31, 2027 will fall below the Perceptive credit facility's minimum revenue covenant. If the lender calls the $65.0 million facility, the Company says it does not have the liquidity to repay it — the explicit basis for the substantial-doubt going-concern language. The ATM is the release valve: $33.1 million remains available after selling 6.25 million shares at an average $1.37 in the first nine months, so further dilution is the likely path to bridging the covenant date.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, STIM was trading at $2.52 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $172.2M. The 52-week trading range was $0.80 to $3.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.